324831 Sigma-AldrichEGF, Human, Recombinant, E. coli
Empfohlene Produkte
Übersicht
Replacement Information |
---|
Key Spec Table
Purity |
---|
≥95% by SDS-PAGE |
Preis & Verfügbarkeit
Bestellnummer | Verfügbarkeit | Verpackung | St./Pkg. | Preis | Menge | |
---|---|---|---|---|---|---|
324831-200UG |
|
Kst.-Ampulle | 200 μg |
|
— |
Product Information | |
---|---|
CAS number | 62229-50-9 |
Form | Solid |
Formulation | Lyophilized from sterile-filtered PBS. |
Quality Level | MQ100 |
Applications |
---|
Physicochemical Information | |
---|---|
Contaminants | Endotoxin: <1.0 EU/μg EGF |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | KB4518000 |
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Bestellnummer | GTIN |
324831-200UG | 04055977216189 |
Documentation
EGF, Human, Recombinant, E. coli SDB
Titel |
---|
EGF, Human, Recombinant, E. coli Analysenzertifikate
Titel | Chargennummer |
---|---|
324831 |
Literatur
Übersicht |
---|
Merlo, G.R., et al. 1995. J. Cell Biol. 128, 1185. Yoshida, T., et al. 1993. Brain Res. Dev. 76, 147. Rubin, J.S., et al. 1991. Proc. Natl. Acad. Sci. USA 88, 415. Carpenter, G., and Wahl, M.I. 1990. In The Epidermal Growth Factor Family in Peptide Growth Factors and Their Receptors (Sporn, M.B., and Roberts, A.B., eds.) Springer-Verlag, New York, p 69. Downward, J., et al. 1984. Nature 311, 483. Gray, A., et al. 1983. Nature 303, 722. Scott, J., et al. 1983. Science 221, 236. Cohen, S. 1960. Proc. Natl. Acad. Sci. USA 46, 302. |